Allergies are, at their core, an inflammatory disease. Every allergic symptom you experience, from a runny nose and itchy eyes to a full-blown asthma attack, is the direct result of your immune system launching an inflammatory response against something that poses little or no real threat. The connection is not incidental; inflammation is the mechanism through which allergies do their damage. But the relationship runs deeper and stranger than most people realize, involving feedback loops between your nerves and immune cells, a gut microbiome that helps set the whole system’s sensitivity, and environmental exposures that can alter allergy risk across generations.
How Mast Cells Start the Fire
The opening act of most allergic reactions centers on a cell called the mast cell. These immune sentinels sit in your skin, gut lining, and airways, packed with granules full of histamine and other inflammatory chemicals. When you encounter an allergen you are sensitized to, antibodies called immunoglobulin E (IgE) that are already bound to the mast cell’s surface recognize the allergen and trigger the cell to dump its contents in a rapid burst known as degranulation.1PubMed Central. Pannexin-1 Channels Are Essential for Mast Cell Degranulation Triggered During Type I Hypersensitivity Reactions This flood of histamine and related chemicals is what causes the immediate symptoms: swelling, redness, mucus production, and that familiar itching. It happens within minutes, and it is fundamentally an inflammatory event.
But the initial burst is only the beginning. Many allergic reactions have a “late phase” that kicks in hours later, driven by a secondary wave of immune cells recruited to the site. In allergic eye inflammation, for example, proteins like periostin help draw eosinophils and basophils into the tissue, amplifying the inflammatory response well after the initial exposure has passed.2PubMed. Periostin deletion suppresses late-phase response in mouse experimental allergic conjunctivitis This two-phase pattern, an immediate flare followed by a sustained inflammatory burn, is a hallmark of allergic disease and explains why symptoms can linger long after you have left the room with the cat in it.
The Cytokines Orchestrating the Response
Behind the scenes, a set of signaling molecules called cytokines coordinates nearly every aspect of allergic inflammation. The most important players are interleukin-4 (IL-4), IL-5, and IL-13. These three proteins have been linked to virtually all the major features of what immunologists call “type 2 inflammation,” the specific flavor of immune response that drives allergies.3PubMed Central. The differential expression of IL-4 and IL-13 and its impact on type-2 immunity IL-4 nudges the immune system toward producing IgE antibodies in the first place. IL-5 mobilizes eosinophils, the white blood cells that pile into allergic tissue and cause much of the collateral damage. IL-13 drives mucus production and airway tightening. Together, they create a self-reinforcing cycle: the more of these cytokines released, the more immune cells recruited, and the more inflammation produced.
In asthma specifically, type 2 airway inflammation driven by IL-4, IL-5, and IL-13 defines the most common and best-understood disease subtype.4PubMed Central. IL5 rs2069812 and IL13 rs1800925 Genetic variants as key determinants of clinically relevant asthma phenotypes Understanding this has been transformative for treatment, as we will see later, because blocking these specific signals can shut down the inflammatory cascade at its source rather than just mopping up after it.
When Skin Barriers Break Down
Allergic inflammation does not always start with inhaling pollen or eating the wrong food. Sometimes it starts with a leaky barrier. Your skin’s outermost layer acts as a physical wall against allergens and microbes. When that barrier is compromised, allergens penetrate more easily and trigger immune responses underneath.5PubMed Central. Significance of Skin Barrier Dysfunction in Atopic Dermatitis Atopic dermatitis (eczema), the most common chronic inflammatory skin disease, is a textbook example. It affects roughly one in five children and one in twenty adults worldwide, and a key genetic risk factor is a mutation in a gene called filaggrin, which produces a protein critical for skin barrier integrity.6Annals of Allergy, Asthma & Immunology. Filaggrin and beyond: New insights into the skin barrier in atopic dermatitis and allergic diseases, from genetics to therapeutic perspectives
The relationship between the barrier defect and inflammation runs in both directions. A compromised barrier lets allergens in, sparking inflammation. But the resulting type 2 inflammatory response then further weakens the barrier by suppressing the very genes that maintain it and altering the composition of the skin’s protective lipids. This creates a vicious cycle: barrier damage causes inflammation, and inflammation worsens the barrier damage, which invites more allergen penetration and more inflammation.
The Nerve-Immune Loop Behind Itch
If you have ever had an allergic itch that seemed to have a mind of its own, there is a biological reason for that. Sensory nerve fibers in your skin and airways are not passive bystanders during allergic inflammation. They are active participants. Type 2 cytokines like IL-4, IL-13, and IL-31 directly activate itch-sensing neurons, and signaling molecules released by damaged skin cells amplify that neural activation further.7PubMed Central. Cross-Talk between Neurons and Immune Cells in Pruritus: from Mechanisms To Medicines The activated nerves then release their own chemical messengers, neuropeptides like substance P and CGRP, which in turn recruit and activate more immune cells.8PubMed Central. Sensory Neuroimmunology: Bidirectional Neuro-Immune Circuits Governing Pain, Itch, Inflammation, and Host Defense at Barrier Surfaces
This bidirectional communication, immune cells talking to nerves and nerves talking back to immune cells, creates a feedback loop that can sustain and amplify allergic inflammation far beyond what the original allergen exposure would warrant. It also helps explain why scratching an itch makes it worse: the mechanical stimulation fires up the same nerve-immune circuits, producing more inflammation and more itch. Periostin, the same protein involved in late-phase allergic eye inflammation, has emerged as a mediator in this nerve-immune conversation, binding to receptors on neurons and triggering immune cells to release itch-promoting signals.
Allergic Inflammation Without IgE
Most people think of allergies as an IgE-driven process, and for many reactions that is accurate. But mast cells can be activated by a surprisingly long list of non-IgE triggers, including complement proteins, neuropeptides, and even certain medications.9PubMed. Non-IgE mediated mast cell activation This matters clinically because it means allergy-like inflammatory reactions can occur even when standard allergy tests (which look for IgE) come back negative.
A receptor called MRGPRX2 has emerged as a key player in these non-IgE reactions. It sits on mast cells and responds to a broad range of positively charged molecules, including certain antibiotics and muscle relaxants used during surgery. MRGPRX2-triggered reactions can occur on first exposure to a drug, without any prior sensitization, which is very different from the classical IgE pathway that requires a previous encounter with the allergen.10PubMed. Mas-related G protein-coupled receptor X2 in non-IgE-mediated mast cell activation and anaphylaxis: a paradigm shift This receptor has also been implicated in chronic hives and neurogenic inflammation, expanding our understanding of what “allergic” inflammation really encompasses.
From Eczema to Asthma
One of the most concerning features of allergic inflammation is its tendency to march through the body over time, a phenomenon clinicians call “the atopic march.” It typically begins with eczema in infancy, progresses to food allergies in early childhood, then moves to allergic rhinitis and asthma. The neuro-immune crosstalk described earlier plays a role in this progression, with pain-sensing nerve fibers helping to orchestrate type 2 immune responses across different tissues.11PubMed. Decoding the neuroimmune axis in the atopic march: mechanisms and implications
Research in animal models has revealed a specific cross-tissue mechanism: when the bacterium Staphylococcus aureus, which commonly colonizes eczema-affected skin, triggers inflammation at the skin surface, it can set off signaling pathways that promote neutrophil-driven lung inflammation far from the original skin site.12PubMed Central. Epicutaneous Staphylococcus aureus initiates cross-tissue IL-36R signaling for neutrophilic lung inflammation in a model of the atopic march Blocking the signaling receptor involved (IL-36R) prevented the lung inflammation from developing in these models, suggesting a potential therapeutic window for interrupting the march before it reaches the airways.
When Inflammation Reshapes the Airways
Chronic allergic inflammation does not just cause symptoms; it can permanently alter tissue structure. In asthma, repeated cycles of inflammation lead to airway remodeling: the smooth muscle around the airways thickens, excess mucus-producing cells develop, and scar-like fibrosis builds up beneath the airway lining.13PubMed Central. Integrated airway epithelial signaling networks linking allergen-driven inflammation to airway remodeling in asthma These structural changes make the airways permanently narrower and more reactive, even during periods when active inflammation is under control.
Eosinophils, those granule-packed immune cells mobilized by IL-5, are increasingly understood as active agents in this process rather than mere bystanders. They release a cocktail of toxic proteins, reactive oxygen species, and inflammatory lipids that directly injure airway tissue. They also interact with the structural cells of the lung to amplify both inflammation and remodeling.14PubMed Central. Molecular Mechanisms Linking Eosinophils to Lung Function Impairment in Respiratory Diseases This is a major reason why controlling allergic inflammation early matters: the structural damage from remodeling is much harder to reverse than the inflammation itself.
Measuring Allergic Inflammation
Doctors do not just rely on symptoms to gauge how much allergic inflammation is happening in your body. Several biomarkers give a window into the underlying process. Fractional exhaled nitric oxide (FeNO) is a breath test that measures a gas produced by inflamed airway cells. In patients with nasal polyps, FeNO levels correlate with eosinophil counts in the nasal tissue and with serum IgE, making it a useful noninvasive snapshot of type 2 inflammation.15PubMed Central. FeNO as a Non-Invasive Biomarker of Type 2 Inflammation in Chronic Rhinosinusitis with Nasal Polyps: Correlation with Serum IgE and Eosinophils
Blood eosinophil counts and total IgE levels are the other standard markers. In partially controlled asthma, FeNO correlates with both blood eosinophil percentage and total IgE, though none of these markers is perfect on its own.16PubMed Central. Association Between FeNO, Total Blood IgE, Peripheral Blood Eosinophil and Inflammatory Cytokines in Partly Controlled Asthma Genetic variation can influence these markers independently of disease severity: certain variants in the IL-6 gene are associated with higher IgE, eosinophils, and FeNO in asthma patients.17PubMed Central. Association between interleukin-6-174G/C gene polymorphism and asthma severity: exploring the role of total serum IgE, blood eosinophils, and FeNO as markers of type 2 inflammation This is one reason why the same biomarker reading can mean different things in different people, and why clinicians typically look at multiple markers together rather than relying on a single number.
How Pollution Turns Up the Volume
The environment you breathe in can amplify allergic inflammation well beyond what the allergen alone would produce. Diesel exhaust particles (DEPs) are among the best-studied culprits. At levels encountered in urban air, DEPs promote the release of inflammatory cytokines, IgE, and oxidants in both the upper and lower airways. They also push the immune system toward the type 2 response pattern associated with allergies, and their immunologic effects are greater when environmental allergens are present at the same time.18PubMed Central. Diesel exhaust and asthma: hypotheses and molecular mechanisms of action In other words, pollution does not just cause its own brand of airway irritation; it specifically amplifies the allergic inflammatory pathway.
Ozone and nitrogen dioxide have similar effects, inducing inflammatory responses involving various immune cells and chemical mediators that worsen allergic disease.19PubMed. Pollution and allergic airways disease In experimental models of severe asthma, diesel exhaust exposure triggers the release of TSLP, one of the alarmin molecules that the airway epithelium produces to alert the immune system, contributing to more intense allergic airway inflammation.20PubMed Central. TSLP contributes to allergic airway inflammation induced by diesel exhaust particle exposure in an experimental model of severe asthma For anyone living in a high-pollution area who notices their allergies are worse than expected, this interaction between pollution and allergic inflammation is probably part of the explanation.
Gut Bacteria and Keeping Inflammation in Check
Your gut microbiome plays a surprising role in setting the threshold for allergic inflammation. The bacteria in your intestines produce short-chain fatty acids (SCFAs), particularly butyrate and propionate, as byproducts of digesting dietary fiber. These molecules strengthen the intestinal barrier, help balance the immune system’s competing factions, and suppress inflammatory cytokine responses, collectively exerting a protective effect against food allergies.21PubMed Central. The Association Between Short-Chain Fatty Acids and the Incidence of Food Allergies—Systematic Review
The protection extends beyond the gut. In animal studies, SCFAs given in drinking water significantly increased the numbers of regulatory T cells, immune cells that suppress inappropriate inflammatory responses, in blood and lymphoid tissues. When those animals were made asthmatic, the SCFA-treated group had more regulatory T cells even in the lung fluid collected after allergen challenge, and less severe allergic airway inflammation.22Journal of Allergy and Clinical Immunology: Global. Short-chain fatty acids ameliorate allergic airway inflammation via sequential induction of PMN-MDSCs and Treg cells This body of research is one reason behind the growing interest in dietary fiber and probiotics as ways to modulate allergic disease, though translating animal findings into reliable human interventions remains a work in progress.
Stress as an Inflammatory Amplifier
If you have ever noticed your allergies flaring during a stressful period, the connection is not in your head, or rather, it starts in your head and then becomes very real in your airways. Psychological stress activates the body’s hormonal stress response, flooding the system with cortisol and adrenaline. Paradoxically, chronic stress can make immune cells resistant to the anti-inflammatory effects of cortisol, which normally serves as the body’s built-in brake on inflammation.23PubMed Central. Social stress and asthma: the role of corticosteroid insensitivity With that brake less effective, airway inflammation in response to allergens, infections, or irritants can escalate more easily.
The stress hormones released by the central nervous system, including glucocorticoids, epinephrine, and norepinephrine, are directly involved in the immune alterations that worsen allergic airway disease. Research has traced a continuous pathway from the brain’s perception of psychological stress all the way to enhanced eosinophilic inflammation in the airways.24PubMed. Neuropsychiatry phenotype in asthma: Psychological stress-induced alterations of the neuroendocrine-immune system in allergic airway inflammation This also has implications for treatment: in chronically stressed asthma patients, standard corticosteroid inhalers may be less effective precisely because the stress has already compromised the cellular machinery those drugs rely on.
Biologics That Target the Inflammatory Machinery
The detailed understanding of allergic inflammation’s molecular machinery has led to a new generation of treatments: biologic therapies. These are lab-made antibodies designed to block specific cytokines or their receptors, essentially cutting specific wires in the inflammatory circuit. Biologics targeting the type 2 pathway have proven highly effective for patients with severe asthma driven by eosinophilic or allergic inflammation, significantly reducing flare-ups and the need for oral steroids in people who were not adequately controlled by high-dose inhaled medications.25Current Pediatrics Reports. Biologic Therapies in Severe Asthma: Current Landscape, Clinical Evidence, and Future Directions
These drugs are also relatively safe compared to older approaches like chronic systemic corticosteroids, and multiple studies have confirmed both their effectiveness and some unanticipated benefits across different allergic conditions.26Journal of Allergy and Clinical Immunology. Allergies and Inflammation: What’s the Connection? The flip side is specificity: because biologics target particular cytokines, they work best when a patient’s inflammation is genuinely driven by those signals. A patient whose asthma is not type 2-driven will not benefit from a drug that blocks IL-5, no matter how effective it is for someone else. This is where the biomarkers discussed earlier become essential for matching the right patient to the right drug.
Omega-3 Fatty Acids and Resolution Pathways
Inflammation is not meant to run indefinitely. Healthy tissues have active resolution pathways that dial down the immune response once the threat is handled. In allergic disease, especially severe asthma, these resolution pathways can be defective, leaving the inflammatory process stuck in the “on” position.27PubMed Central. Reprogramming Inflammatory Macrophages with Specialized Pro-Resolving Lipid Mediators: A Novel Immunotherapeutic Strategy for Asthma A group of molecules called specialized pro-resolving mediators (SPMs), generated from omega-3 fatty acids like EPA and DHA, actively counter-regulate eosinophilic airway inflammation and promote resolution.28Allergology International. Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases
This is part of the rationale for interest in omega-3 supplementation for allergic conditions. Fish oil and similar sources provide the raw materials from which the body manufactures these pro-resolving signals, and omega-3 fatty acids broadly oppose the inflammatory effects of omega-6 fatty acids that dominate the modern Western diet.29PubMed Central. Can Early Omega-3 Fatty Acid Exposure Reduce Risk of Childhood Allergic Disease? Whether supplementation actually prevents or meaningfully reduces established allergic disease in humans remains an open question, but the biological logic connecting omega-3 intake to reduced allergic inflammation is well grounded.
Why Allergies Follow a Clock
Anyone who has noticed their allergies are worse at certain times of day is not imagining things. Allergic disease shows marked day-night variations in both symptoms and the laboratory markers that track underlying inflammation. Research indicates that the body’s internal circadian clock, the biological oscillator that drives roughly 24-hour cycles in behavior and physiology, underpins these time-of-day-dependent swings in allergic reactivity.30PubMed. Clockwork allergy: How the circadian clock underpins allergic reactions Mast cell responsiveness, immune cell trafficking, and cortisol levels all fluctuate with the circadian cycle, meaning the same allergen exposure can provoke a substantially different inflammatory response depending on when it occurs. Nocturnal asthma worsening, for instance, aligns with the nighttime drop in circulating cortisol and the peak in certain pro-inflammatory pathways.
Epigenetic Inheritance of Allergy Risk
Perhaps the most unsettling dimension of the allergy-inflammation connection is that it can be passed down without any change to your actual DNA sequence. Environmental exposures, particularly during pregnancy and early life, can modify how genes are read and expressed through epigenetic mechanisms, alterations that sit on top of the genetic code and act like volume dials for specific genes. These changes can affect immune development and allergic susceptibility.31PubMed Central. The Effects of Environmental Exposure on Epigenetic Modifications in Allergic Diseases
Animal research has demonstrated that a single exposure to diesel exhaust particles during pregnancy can elevate allergy susceptibility not only in the directly exposed offspring but also in the second and, with lesser magnitude, the third generation. Distinct changes in DNA methylation patterns were identified in immune cells across all three generations, and the shared altered sites included genes involved in chromatin modification, suggesting multiple layers of epigenetic change interact with one another.32PubMed Central. Transgenerational transmission of asthma risk after exposure to environmental particles during pregnancy Preliminary human studies similarly suggest that early environmental effects on immune development may be mediated epigenetically and that these effects are potentially heritable.33PubMed Central. The role of epigenetic dysregulation in the epidemic of allergic disease The implication is sobering: the pollution or chemical exposure a pregnant woman experiences today could influence her grandchild’s likelihood of developing allergic inflammation decades later.
An Evolutionary Perspective on Why This System Exists
Given all the misery allergies cause, it is reasonable to wonder why evolution preserved such a hair-trigger inflammatory system in the first place. The IgE-driven response that underlies most allergies appears to have evolved as a defense against parasitic worms, venomous stings, and environmental toxins. Recent research has challenged the long-standing characterization of allergens as “harmless” substances, arguing instead that many common allergens share structural or enzymatic features with genuinely dangerous agents. Under this framework, the allergic response evolved to have adaptive value, and allergens may act as proxies that the immune system mistakes for more threatening molecules.34PubMed. Allergy in an Evolutionary Framework In environments where parasites and venomous creatures posed daily threats, a system prone to overreacting was safer than one prone to underreacting. The modern epidemic of allergic disease may represent the cost of running that ancient defensive program in an environment where the original threats have largely disappeared, leaving a well-armed inflammatory system with too little to do and too many false alarms to chase.